3b Blackbio Dx Ltd vs Hemant Surgical Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 30, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1359 as of 29 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Hemant Surgical Industries Ltd changed from 12.9 on March 2025 to 15.6 on March 2026 . This represents a CAGR of 9.97% over 2 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Hemant Surgical Industries Ltd changed from ₹ 104.03 crore on March 2025 to ₹ 283.59 crore on March 2026 . This represents a CAGR of 65.11% over 2 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Hemant Surgical Industries Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Hemant Surgical Industries Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Hemant Surgical Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Hemant Surgical Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Hemant Surgical Industries Ltd

Hemant Surgical Industries Limited was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Mumbai.
Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai. Company is in the business of Medical Equipment & Supplies in Mumbai.
Its product basket cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables.
In addition, the Company is providing services for maintenance and in running of 5 dialysis centres. The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd.

FAQs for the comparison of 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Hemant Surgical Industries Ltd?

Market cap of 3B Blackbio DX Ltd is 1,166 Cr while Market cap of Hemant Surgical Industries Ltd is 850 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd?

The stock performance of 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd?

As of October 30, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1359.45. On the other hand, Hemant Surgical Industries Ltd stock price is INR ₹585.0.

How do dividend payouts of 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Hemant Surgical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.